VeritasInSilico Inc. Announces Completion of Shinkawasaki Laboratory Relocation and Opening of Kawasaki Laboratory

Key facts

  • VeritasInSilico Inc. Announces Completion of Shinkawasaki Laboratory Relocation and Opening of Kawasaki Laboratory
  • Drug discovery venture Veritas In Silico has relocated its Shinkawasaki laboratory and opened a new Kawasaki laboratory. The objective is to strengthen its R&D system to accelerate mRNA-targeted drug discovery, showing ambition for business expansion.
  • Source: PR Times
  • Date: April 22, 2026

Direct answer

Drug discovery venture Veritas In Silico has relocated its Shinkawasaki laboratory and opened a new Kawasaki laboratory. The objective is to strengthen its R&D system to accelerate mRNA-targeted drug discovery, showing ambition for business expansion.

Citation
VeritasInSilico Inc. Announces Completion of Shinkawasaki Laboratory Relocation and Opening of Kawasaki Laboratory (April 22, 2026), PR Times
Source
PR Times
Date
April 22, 2026
Drug discovery venture Veritas In Silico has relocated its Shinkawasaki laboratory and opened a new Kawasaki laboratory. The objective is to strengthen its R&D system to accelerate mRNA-targeted drug discovery, showing ambition for business expansion.
その他NQ 0/100出典：PR Times

📋 Article Processing Timeline

  • 📰 Published: April 22, 2026 at 17:08
  • 🔍 Collected: April 22, 2026 at 17:32 (23 min after Published)
  • 🤖 AI Analyzed: April 22, 2026 at 21:00 (3h 28m after Collected)
Veritas In Silico possesses the ibVIS® platform, which enables the creation of small molecule and nucleic acid drugs targeting the partial structures of mRNA, and conducts mRNA-targeted drug discovery research in partnership with pharmaceutical companies.

FAQ

What are the key facts in this article?

Drug discovery venture Veritas In Silico has relocated its Shinkawasaki laboratory and opened a new Kawasaki laboratory. The objective is to strengthen its R&D system to accelerate mRNA-targeted drug discovery, showing ambition for business expansion.

What is the direct answer?

Drug discovery venture Veritas In Silico has relocated its Shinkawasaki laboratory and opened a new Kawasaki laboratory. The objective is to strengthen its R&D system to accelerate mRNA-targeted drug discovery, showing ambition for business expansion.

What is the source and date?

PR Times: https://prtimes.jp/main/html/rd/p/000000015.000079667.html | April 22, 2026

Back to Newsroom (16)